Intralesional interferon therapy for basal cell carcinoma-Reference-Cited by-同舟云学术

Intralesional interferon therapy for basal cell carcinoma

Published:1990-10 Issue:4 Volume:23 Page:694-700
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Cornell Roger C.,Greenway Hubert T.,Tucker Stephen B.,Edwards Libby,Ashworth Susan,Vance J. Corwin,Tanner Daniel J.,Taylor Eugene L.,Smiles Kenneth A.,Peets Edwin A.

Publisher

Elsevier BV

Subject

Dermatology

Reference32 articles.

1. Cancer statistics;Silverberg;Cancer,1986

2. Multivariate risk score for recurrence of cutaneous basal cell carcinomas;Dubin;Arch Dermatol,1983

3. Basal cell carcinoma of the skin recurrence rate after different types of treatment;Reymann;Dermatologica,1980

4. Curettage-electrc-desiccation treatment of basal cell carcinomas;Kopf;Arch Dermatol,1977

5. The interferons: a clinician's view;Landow;Dermatol Clin,1988

Cited by 184 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and emerging intralesional immunotherapies in cutaneous oncology;Journal of the American Academy of Dermatology;2024-06

2. Long-term follow-up of patients with high-risk facial basal cell carcinoma treated with interferon;Anais Brasileiros de Dermatologia;2024-05

3. Viscum Album Lipophilic Extract in Actinic Keratosis, Cutaneous Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Retrospective Case Series;Complementary Medicine Research;2024

4. Treatment of basal cell carcinoma with intralesional interferon alfa-2b: an open-label clinical trial;Expert Review of Anticancer Therapy;2023-06-05

5. Immunotherapy for keratinocyte cancers. Part I: Immune-related epidemiology, risk factors, pathogenesis, and immunotherapy management of keratinocyte cancers;Journal of the American Academy of Dermatology;2023-06